Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by bligickaon Oct 21, 2020 9:33pm
92 Views
Post# 31759940

RE:RE:RE:Interesting Days Ahead

RE:RE:RE:Interesting Days Ahead9 months from now they plan to begin phase 1 trials ......l thought that's why they are crunching the data right now that has taken like 3 months to analyze.... so what are they going to do for 9 months plan thr phase 1 trial .....absolutely ridiculous !!! Who the fuuck would hold their capital in this turtle for that long while several phase 3 trials are coming to a conclusion....vaccines are already being mass produced and are ready to go when approval is granted probably by the end of the year
Valuehunter72 wrote:

Sounds like you better hit that sell button BigLicka.  The 9 month timeline was very clear, for all to see in their latest presentation.  I agree with you....9 months seems crazy when you have close to 50 other candidates in clinical already.  I am holding some back....just in case.  Somehow I see Mr Goren under promising and about to over deliver.....but that is simply just a hunch of mine.  I have grown to like this jockey even more recently.  It's a love hate thing with David and I.  



<< Previous
Bullboard Posts
Next >>